Share
2,893 Posts.
lightbulb Created with Sketch. 241
clock Created with Sketch. 20/09/21
12:55
Share
Originally posted by ainsleym:
↑
Could not have put it better myself. In my view its gone from a beauty queen to an ugly ducking which then morphed into a dog and today I would call it a dog of a stock with fleas. And I note today another biotech company announced it was running clinical trials overseas... where, in India, covid related trials admittedly but still, it shows ASX biotech companies are prepared to go elsewhere for recruiting cohorts, recently one underway in Japan with a Japanese partner and before that another I recall ran trials in Eastern Europe due lower costs and faster recruitment. I hope to high heaven our management have Plan B if required that embraces recruitment somewhere else other than Oz, In fact I just hope we have a Plan B, full stop.
Expand
Agree, glad I sold 80% of my holdings a few months ago (wish I had sold the lot). Will wait until we are sub-3c and may consider going hard at that price. Company seems to be going backwards fast.
